BDR Pharma launches generic Palbociclib for breast cancer treatment EP News Bureau Jan 13, 2023 The drug will be made available in three strengths i.e. – 125 mg, 100 mg and 75 mg capsules priced at Rs 3,150 for 75 mg; Rs 3,600…
New Novartis data show Piqray effectiveness across key biomarkers in patients with HR+/HER2-… EP News Bureau Jun 6, 2022 Biomarker analysis from phase-III Solar-1 study shows Piqray plus fulvestrant had clinical benefit regardless of presence of ESR1…
